Ivosidenib

Back to search

Molecule Structure

Scientific Name

Ivosidenib

Description of the Drug

Ivosidenib is an isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB14568

Brand Name(s)

Tibsovo

Company Owner(s)

Servier Pharmaceuticals Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Isocitrate dehydrogenase [NADP] cytoplasmic SINGLE PROTEIN INHIBITOR CHEMBL2007625

Unichem Links

SureChEMBL SCHEMBL15122512
DrugBank DB14568
PubChem 71657455
BindingDB 363689
DrugCentral 5292
ChemicalBook CB32738771
Guide to Pharmacology 9217
GSRS 2319ec1c-143a-4297-9f67-612c35d66ab1
rxnorm TIBSOVO IVOSIDENIB
ChEBI 145430
ZINC ZINC000205136523